Vanessa Drendel
Papers
1
Total Citations
30
H-Index
1
About
Vanessa Drendel is a leading researcher in urologic oncology, with a primary focus on improving the diagnostic accuracy of prostate cancer detection. Her most cited work, a 2016 study on robot-guided, software-based transperineal MRI/TRUS fusion biopsy, has garnered 30 citations and represents a significant contribution to the field. In this pivotal study, Drendel and her team compared cancer detection rates between MRI-TRUS fusion targeted and systematic biopsies in a high-risk population of previously biopsy-negative men. By demonstrating the efficacy of this advanced, robot-guided approach, her research directly addresses the critical challenge of diagnosing clinically significant prostate cancer while minimizing false negatives. This work has helped validate the use of fusion biopsy techniques, offering a less invasive and more precise alternative to traditional methods. Drendel’s contributions are essential for clinicians seeking to improve patient outcomes, particularly in complex cases where prior biopsies have failed to detect malignancy, solidifying her reputation as a key innovator in prostate cancer diagnostics.
Research Focus
Key Achievements
Top Papers
- 1